← Browse by Condition
Medical Condition
primary peritoneal cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT05086692 Phase 1, Phase 2
Recruiting
A Beta-only IL-2 ImmunoTherapY Study
Enrollment
115 pts
Location
United States, Austr...
Sponsor
Medicenna Therapeutics, Inc.
NCT05574673
Recruiting
Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype
Enrollment
1,000 pts
Location
Denmark
Sponsor
Nordic Society of Gynaecologic...